Showing results (141-150 of 202) with videos related to
Sort By:
Pageof 21
Journal of Medicinal Chemistry|December 5, 2008
Interactions between human glutamate carboxypeptidase II and urea-based inhibitors: structural characterizationCyril Barinka, Youngjoo Byun, Crystal L Dusich, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 16, 2017
5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in MiceVladimir M Pogorelov, Ramona M Rodriguiz, Jianjun Cheng, et al.Journal of Medicinal Chemistry|February 3, 2006
Synthesis and structure-activity relationships of 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine analogues as potent, noncompetitive metabotropic glutamate receptor subtype 5 antagonists; search for cocaine medicationsYasuyoshi Iso, Ewa Grajkowska, Jarda T Wroblewski, et al.Bioorganic & Medicinal Chemistry|March 5, 2003
2,3-Disubstituted quinuclidines as a novel class of dopamine transporter inhibitorsSukumar Sakamuri, Istvan J Enyedy, Wahiduz A Zaman, et al.Molecular Imaging|August 19, 2003
11C-MCG: synthesis, uptake selectivity, and primate PET of a probe for glutamate carboxypeptidase II (NAALADase)Martin G Pomper, John L Musachio, Jiazhong Zhang, et al.Nature Communications|December 20, 2013
Indoleamides are active against drug-resistant Mycobacterium tuberculosisShichun Lun, Haidan Guo, Oluseye K Onajole, et al.Journal of the American Chemical Society|December 23, 2004
Isoxazolyl-serine-based agonists of peroxisome proliferator-activated receptor: design, synthesis, and effects on cardiomyocyte differentiationZhi-Liang Wei, Pavel A Petukhov, Fero Bizik, et al.Chemmedchem|April 28, 2009
Searching for disease modifiers-PKC activation and HDAC inhibition - a dual drug approach to Alzheimer's disease that decreases Abeta production while blocking oxidative stressAlan P Kozikowski, Yihua Chen, Tapadar Subhasish, et al.Nature Medicine|July 26, 2011
HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth diseaseConstantin d'Ydewalle, Jyothsna Krishnan, Driss M Chiheb, et al.The Journal of Biological Chemistry|July 17, 2007
Phosphatidylinositol ether lipid analogues that inhibit AKT also independently activate the stress kinase, p38alpha, through MKK3/6-independent and -dependent mechanismsJoell J Gills, S Sianna Castillo, Chunyu Zhang, et al.Pageof 21